These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8357159)

  • 21. The thymus in myasthenia gravis.
    Wekerle H
    Ann N Y Acad Sci; 1993 Jun; 681():47-55. PubMed ID: 8357188
    [No Abstract]   [Full Text] [Related]  

  • 22. Antibodies to synthetic peptide (125-148) of the alpha-subunit of human nicotinic acetylcholine receptor in sera from patients with myasthenia gravis.
    Ohta M; Ohta K; Itoh N; Nishitani H; Hara H; Hayashi K
    Neurology; 1990 Nov; 40(11):1776-8. PubMed ID: 2234435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thymic remodeling associated with hyperplasia in myasthenia gravis.
    Le Panse R; Bismuth J; Cizeron-Clairac G; Weiss JM; Cufi P; Dartevelle P; De Rosbo NK; Berrih-Aknin S
    Autoimmunity; 2010 Aug; 43(5-6):401-12. PubMed ID: 20402580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myasthenia gravis studied by monoclonal antibodies to the acetylcholine receptor.
    Tzartos SJ
    In Vivo; 1988; 2(1):105-10. PubMed ID: 2979808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences between the epsilon and gamma subunits of the acetylcholine receptor (AChR) may be significant in autoimmune myasthenia gravis.
    Ragheb S; Lisak RP
    Ann N Y Acad Sci; 2003 Sep; 998():336-8. PubMed ID: 14592892
    [No Abstract]   [Full Text] [Related]  

  • 26. [Advances in the research on immunopathogenesis of myasthenia gravis].
    Zieliński M; Kuzdzał J; Soja J; Szlubowski A
    Neurol Neurochir Pol; 2003; 37(5):1085-94. PubMed ID: 15174254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human x human hybridomas from patients with myasthenia gravis: possible tools for idiotypic therapy for myasthenia.
    Blair DA; Mihovilovic M; Agius MA; Fairclough RH; Richman DP
    Ann N Y Acad Sci; 1987; 505():155-67. PubMed ID: 3500665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
    Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
    Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antibodies to acetylcholine receptor. Diagnosis and therapeutic interest in myasthenia gravis (author's transl)].
    de Crousaz G
    Ann Chir; 1980 Mar; 34(3):188-92. PubMed ID: 7369693
    [No Abstract]   [Full Text] [Related]  

  • 30. Human muscle acetylcholine receptor reactive T and B lymphocytes in myasthenia gravis.
    Yi Q; Lefvert AK
    Ann N Y Acad Sci; 1993 Jun; 681():339-41. PubMed ID: 8357186
    [No Abstract]   [Full Text] [Related]  

  • 31. ELISA for detection of IgG & IgM antibodies to human nicotinic acetylcholine receptor in myasthenia gravis.
    Jailkhani BL; Asthana D; Jaffery NF; Khajuria A; Subbalaxmi B; Ahuja GK
    Indian J Med Res; 1986 Feb; 83():187-95. PubMed ID: 3710546
    [No Abstract]   [Full Text] [Related]  

  • 32. The auto-antigen repertoire in myasthenia gravis.
    Vrolix K; Fraussen J; Molenaar PC; Losen M; Somers V; Stinissen P; De Baets MH; Martínez-Martínez P
    Autoimmunity; 2010 Aug; 43(5-6):380-400. PubMed ID: 20380581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental autoimmune myasthenia gravis induced by thymic acetylcholine receptor-like protein.
    Kawanami S; Mori S
    Fukuoka Igaku Zasshi; 1994 Apr; 85(4):120-7. PubMed ID: 8200609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sharing of epitopes by bacteria and the nicotinic acetylcholine receptor: a possible role in the pathogenesis of myasthenia gravis.
    Stefansson K; Dieperink ME; Richman DP; Marton LS
    Ann N Y Acad Sci; 1987; 505():451-60. PubMed ID: 2446557
    [No Abstract]   [Full Text] [Related]  

  • 35. [B cell population and its autoimmune activity in the thymus of patients associated with myasthenia gravis].
    Yoshitake T; Takahama T; Kanai F; Ohnishi K; Suzuki T; Kametani Y; Itoyama S; Sugawara I; Matsunaga A
    Kyobu Geka; 1993 Dec; 46(13):1083-7; discussion 1087-9. PubMed ID: 8258907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muscle nicotinic acetylcholine receptor mRNA expression in hyperplastic and neoplastic myasthenia gravis thymus.
    MacLennan CA; Beeson D; Willcox N; Vincent A; Newsom-Davis J
    Ann N Y Acad Sci; 1998 May; 841():407-10. PubMed ID: 9668266
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunology of the nicotinic acetylcholine receptor.
    Fuchs S
    Curr Top Microbiol Immunol; 1979; 85():1-29. PubMed ID: 114357
    [No Abstract]   [Full Text] [Related]  

  • 38. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
    Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D
    Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular and structural characterization of anti-acetylcholine receptor antibodies in experimental autoimmune myasthenia gravis.
    Graus YM; De Baets MH
    Adv Neuroimmunol; 1994; 4(4):457-74. PubMed ID: 7719618
    [No Abstract]   [Full Text] [Related]  

  • 40. Therapeutic immunoadsorption of acetylcholine receptor antibodies in myasthenia gravis.
    Sato T; Ishigaki Y; Komiya T; Tsuda H
    Ann N Y Acad Sci; 1988; 540():554-6. PubMed ID: 3061349
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.